Virtual Event: Antibody Drug Conjugates Revisited

Virtual Event: ADCs Revisited

BioPharmaSpec's Technical Director of Structural Analysis, Dr. Richard L. Easton, will speak at this event with a presentation entitled "Measuring the Drug Antibody Ratio (DAR) and the Site(s) of Conjugation in Antibody Drug Conjugates."

ADCs are an exciting area of research, but can pose additional analytical challenges over traditional antibody characterization. The structural complexity of ADCs and the fact they are a relatively new area of research, with limited regulatory experience, increases the uncertainty around some aspects of discovery and development. This symposium brings together experts from various disciplines and fields of research across the industry to share their knowledge in order to advance understanding and accelerate the development of these exciting molecules.